Michelle L. Edwards

发表

1993-2003 Gender Differences in Coronary Artery Revascularization: Has Anything Changed?

N. Albert, C. Apperson-Hansen, Michelle L. Edwards, 2005, The Journal of cardiovascular nursing.

Evidence-based practice for acute decompensated heart failure.

C. Eastwood, N. Albert, Michelle L. Edwards, 2004, Critical care nurse.

Increased cost effectiveness with nesiritide vs. milrinone or dobutamine in the treatment of acute decompensated heart failure.

R. Delgado, N. Scroggins, Michelle L. Edwards, 2005, Congestive heart failure.

BREAKWATER: Randomized phase 3 study of encorafenib (enco) + cetuximab (cetux) ± chemotherapy for first-line (1L) treatment (tx) of BRAF V600E-mutant (BRAFV600E) metastatic colorectal cancer (mCRC).

J. Desai, E. Van Cutsem, J. Tabernero, 2021 .

COLUMBUS 5-Year Update: A Randomized, Open-Label, Phase III Trial of Encorafenib Plus Binimetinib Versus Vemurafenib or Encorafenib in Patients With BRAF V600–Mutant Melanoma

D. Schadendorf, K. Flaherty, P. Ascierto, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study

Sarah F. Griffee, Susan M. Kilroy, Philip Smith, 2022, The Lancet Gastroenterology & Hepatology.

The heart failure clinic: a consensus statement of the Heart Failure Society of America.

Douglas Gregory, C. O'connor, M. Rich, 2008, Journal of cardiac failure.

Biomarker testing in patients (pts) with metastatic colorectal cancer (mCRC): Survey of U.S. oncologists (ONC) in rural areas and urban clusters.

C. Lieu, Mark A Lewis, Michelle L. Edwards, 2021, Journal of Clinical Oncology.

Five-year overall survival (OS) in COLUMBUS: A randomized phase 3 trial of encorafenib plus binimetinib versus vemurafenib or encorafenib in patients (pts) with BRAF V600-mutant melanoma.

D. Schadendorf, K. Flaherty, P. Ascierto, 2021 .

Anticoagulation Therapy In Heart Failure Patients With Normal Heart Rhythm: A Review Of The Evidence

Michelle L. Edwards, 2009 .

The enigma of heart disease in women: New insights may precipitate diagnosis and improve patient outcomes

Michelle L. Edwards, 2012, Journal of the American Academy of Nurse Practitioners.

A Phase Ib/II Study of WNT974 + Encorafenib + Cetuximab in Patients With BRAF V600E-Mutant KRAS Wild-Type Metastatic Colorectal Cancer

E. Van Cutsem, J. Tabernero, V. Morris, 2023, The oncologist.

1041MO 5-year update on COLUMBUS: A randomized phase III trial of encorafenib (enco) + binimetinib (bini) versus enco or vemurafenib (vem) in patients (pts) with BRAF V600-mutant melanoma

D. Schadendorf, K. Flaherty, P. Ascierto, 2021, Annals of Oncology.

Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial

Marcelo A. Falappa, Tariq M. Alhawassi, A. Laupacis, 2021, BMJ.

Phase Ib/II Study of the Efficacy and Safety of Binimetinib (MEK162) Plus Panitumumab for Mutant or Wild-Type RAS Metastatic Colorectal Cancer

T. Zander, E. Van Cutsem, M. Ducreux, 2023, The oncologist.